Your browser doesn't support javascript.
loading
Anticoagulant therapy with rivaroxaban in a young patient  with paroxysmal nocturnal hemoglobinuria.
Dragoni, Francesco; Chiarotti, Flavia; Lombardi, Laura; Iori, Anna Paola; Cafolla, Arturo.
Afiliação
  • Dragoni F; Thrombosis Center, Department of "Cellular Biotechnologies and Hematology", "Sapienza" University Rome, Italy.
  • Chiarotti F; Department of "Biologia cellulare e Neuroscienze", Istituto Superiore di Sanità Rome, Italy.
  • Lombardi L; Thrombosis Center, Department of "Cellular Biotechnologies and Hematology", "Sapienza" University Rome, Italy.
  • Iori AP; Thrombosis Center, Department of "Cellular Biotechnologies and Hematology", "Sapienza" University Rome, Italy.
  • Cafolla A; Thrombosis Center, Department of "Cellular Biotechnologies and Hematology", "Sapienza" University Rome, Italy.
Clin Case Rep ; 3(10): 790-2, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26509007
ABSTRACT
The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália